Insulin pump benefits ‘misplaced and unfounded’

It’s “misplaced and unfounded” to assume all type 1 patients will benefit from insulin pump therapy or continuous glucose monitoring over conventional insulin therapy, a UK professor has argued.

Professor Carlo Acerini from the University of Cambridge says the clinical evidence base for insulin pumps and CGM has not been consistently demonstrated.

Systematic reviews and meta-analyses have